Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure

NCT04385589 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Dapagliflozin
DRUG: insulin

Sponsor

Assiut University